welireg - belzutifan tablet, film coated
(Belzutifan)Merck Sharp & Dohme Llc
Usage: Welireg treats adults with von Hippel-Lindau (VHL) disease for associated RCC, CNS hemangioblastomas, or pancreatic neuroendocrine tumors not needing immediate surgery; adults with advanced RCC with clear cell component after prior PD-1/PD-L1 and VEGF-TKI therapy; and patients 12+ with advanced or metastatic pheochromocytoma or paraganglioma.